Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE agrees approval deal for ultra-rare juvenile bone disease

July 5, 2017
Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …

News
8384110298_da510e0347_c

Google’s DeepMind app deal with NHS brought into question

July 5, 2017
Medical Communications, Research and Development Alphabet, DeepMind, NHS, google

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …

News
shutterstock_159488225

Tumour genome mapping could lead to improved outcomes, research finds

July 5, 2017
Research and Development Cancer, Hi-C

A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …

News
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

Feature
shutterstock_38078521

Researchers boost existing antibiotic to tackle drug resistance

July 4, 2017
Research and Development University of Lincoln, antibiotic resistance

The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …

News

Stada CEO and CFO tumble in takeover turmoil

July 4, 2017
Sales and Marketing Bain capital, Cinven, Stada

Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …

News
sunpharma

Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug

July 4, 2017
Manufacturing and Production Samsung BioLogics, Sun Pharma

India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …

News

Johnson & Johnson face major lawsuit over vaginal mesh

July 4, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh

Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …

News
shutterstock_146497481

Top CMO pushes for routine genome screening on NHS

July 4, 2017
Manufacturing and Production, Research and Development NHS, genome sequencing

England’s top Chief Medical Officer has called for routine DNA testing to become standard on the NHS in a bid …

News
brexit_flag_0

Ministers move to clarify drug regulation Post-Brexit

July 4, 2017
Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

News
astrazeneca_building_white

AstraZeneca generates $600 million from just two drug sales

July 3, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig

AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …

News

Forging a path forward in neurological disorders

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …

Feature
index_ph001

Big success and even bigger failure for Daiichi Sankyo’s experimental therapy

July 3, 2017
Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin

Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …

News
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017
Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …

News
astrazeneca_sign_sky

New Pfizer EU approval offers first treatment option for leukaemia subtype

July 3, 2017
Sales and Marketing AstraZeneca, Besponsa, EU, European Commission

Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …

News
veeva_webinar

Free Webinar: How will quality management change by 2025?

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva

Following on from the success of our previous free webinar sessions, Pharmafocus is partnering

News

NICE recommends AstraZeneca lung treatment

July 3, 2017
Sales and Marketing AstraZeneca, Daxas, NICE

AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …

News

Pricing Consultant Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)

Appointment

Head of Product Innovation Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)

Appointment

Development Manager Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …

Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026